The Overall Response Rate Of Azacitidine In Patients With Intermidiate-2 And High Risk Myelodysplastic Syndromes- A Retrospective Chart Review Study From Greece
Abstract
Authors
V Pappa V Fragoulakis N Maniadakis E Briasoulis K Tsionos A Kioumi E Vervesou A Symeonidis